ADVERTISEMENT
Search

Pharmacy News

CDC releases detailed adult immunization schedule for 2024, with revisions

CDC’s adult immunization schedule for 2024, which was published in the Annals of Internal Medicine on January 12, 2024, includes updates for several vaccines, including those for respiratory syncytial virus (RSV), meningitis, mpox, and COVID-19. The immunization schedule is based on the recommendations of CDC’s ACIP.

Early tecovirimat treatment for mpox disease may benefit people with HIV

Early intervention with tecovirimat may stop an mpox infection from advancing to the stages of severe disease in people living with HIV (PWH), new research suggests.

Research looks at Paxlovid for long COVID risk

Paxlovid did not reduce the risk of developing long COVID in vaccinated, nonhospitalized adults, according to new data published in the Journal of Medical Virology.

Labeling will change for two cholesterol-lowering medications

Effective immediately, FDA has changed the labels on two medications used to bring down LDL cholesterol levels: bempedoic acid (Nexletol) and bempedoic acid/ezetimibe (Nexlizet).

FDA finalizes guidance over benzene carcinogen in drugs

In final guidance that takes effect immediately, FDA restricted manufacturers from using benzene in new and existing prescription drugs as well as nonprescription interventions.

RSS
First678911131415Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT